Low-risk transfusion-related acute lung injury donor strategies and the impact on the onset of transfusion-related acute lung injury: A meta-analysis

Transfusion

Volumn 55, Issue 1, 2015, Pages 164-175

  Müller, Marcella C A ^a   Van Stein, Danielle ^a   Binnekade, Jan M ^a   Van Rhenen, Dick J ^a   Vlaar, Alexander P J ^a,b  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b Laboratory of Experimental Intensive Care and Anesthesiology ^*  (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BIBLIOGRAPHIC DATABASE; BLOOD BANK; BLOOD DONOR; BLOOD TRANSFUSION; CASE CONTROL STUDY; HUMAN; META ANALYSIS; OUTCOME ASSESSMENT; PATIENT SELECTION; POPULATION; QUALITY CONTROL; SYSTEMATIC REVIEW; TRANSFUSION RELATED ACUTE LUNG INJURY; ACUTE LUNG INJURY; ADVERSE EFFECTS; DONOR SELECTION; MALE; METHODOLOGY; MORTALITY; OBSERVATIONAL STUDY; PLASMA; RESPIRATORY DISTRESS SYNDROME, ADULT; RETROSPECTIVE STUDY; RISK REDUCTION; STANDARDS; TRANSFUSION REACTION;

ACUTE LUNG INJURY; BLOOD DONORS; BLOOD TRANSFUSION; CASE-CONTROL STUDIES; DONOR SELECTION; HUMANS; MALE; OBSERVATIONAL STUDY AS TOPIC; PLASMA; RESEARCH DESIGN; RESPIRATORY DISTRESS SYNDROME, ADULT; RETROSPECTIVE STUDIES; RISK REDUCTION BEHAVIOR; TRANSFUSION REACTION;

EID: 84920874105     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/trf.12816     Document Type: Article

References (44)

1. Food and Drug Administration. Fatalities reported to FDA following blood collection and transfusion: annual summary for fiscal year 2012. 2013. [cited 2013 Sep 7]. Available from: http://www.fda.gov/BiologicsBloodVaccines/SafetyAvailability/ReportaProblem/TransfusionDonationFatalities/ucm346639.htm
2. Kleinman S, Caulfield T, Chan P, et al. Toward an understanding of transfusion-related acute lung injury: statement of a consensus panel. Transfusion 2004; 44: 1774-1789.
3. Vlaar AP, Juffermans NP,. Transfusion-related acute lung injury: a clinical review. Lancet 2013; 382: 984-994.
4. Silliman CC,. The two-event model of transfusion-related acute lung injury. Crit Care Med 2006; 34 (5 Suppl): S124-131.
5. Mangalmurti NS, Xiong Z, Hulver M, et al. Loss of red cell chemokine scavenging promotes transfusion-related lung inflammation. Blood 2009; 113: 1158-1166.
6. Vlaar AP, Hofstra JJ, Levi M, et al. Supernatant of aged erythrocytes causes lung inflammation and coagulopathy in a "two-hit" in vivo syngeneic transfusion model. Anesthesiology 2010; 113: 92-103.
7. Vlaar AP, Hofstra JJ, Kulik W, et al. Supernatant of stored platelets causes lung inflammation and coagulopathy in a novel in vivo transfusion model. Blood 2010; 116: 1360-1368.
8. Popovsky MA, Abel MD, Moore SB,. Transfusion-related acute lung injury associated with passive transfer of antileukocyte antibodies. Am Rev Respir Dis 1983; 128: 185-189.
9. Curtis BR, McFarland JG,. Mechanisms of transfusion-related acute lung injury (TRALI): anti-leukocyte antibodies. Crit Care Med 2006; 34 (5 Suppl): S118-123.
10. Popovsky MA, Moore SB,. Diagnostic and pathogenetic considerations in transfusion-related acute lung injury. Transfusion 1985; 25: 573-577.
11. Holness L, Knippen MA, Simmons L, et al. Fatalities caused by TRALI. Transfus Med Rev 2004; 18: 184-188.
12. Popovsky MA, Davenport RD,. Transfusion-related acute lung injury: femme fatale? Transfusion 2001; 41: 312-315.
13. van Stein D, Beckers EA, Sintnicolaas K, et al. Transfusion-related acute lung injury reports in the Netherlands: an observational study. Transfusion 2010; 50: 213-220.
14. Densmore TL, Goodnough LT, Ali S, et al. Prevalence of HLA sensitization in female apheresis donors. Transfusion 1999; 39: 103-106.
15. Chapman CE, Stainsby D, Jones H, et al. Ten years of hemovigilance reports of transfusion-related acute lung injury in the United Kingdom and the impact of preferential use of male donor plasma. Transfusion 2009; 49: 440-452.
16. Muller MC, Juffermans NP,. Transfusion-related acute lung injury: a preventable syndrome? Expert Rev Hematol 2012; 5: 97-106.
17. Muller MC, Porcelijn L, Vlaar AP,. Prevention of immune-mediated transfusion-related acute lung injury; from bloodbank to patient. Curr Pharm Des 2012; 18: 3241-3248.
18. Arinsburg SA, Skerrett DL, Karp JK, et al. Conversion to low transfusion-related acute lung injury (TRALI)-risk plasma significantly reduces TRALI. Transfusion 2012; 52: 946-952.
19. Eder AF, Dy BA, Perez JM, et al. The residual risk of transfusion-related acute lung injury at the American Red Cross (2008-2011): limitations of a predominantly male-donor plasma mitigation strategy. Transfusion 2013; 53: 1442-1449.
20. Funk MB, Guenay S, Lohmann A, et al. Benefit of transfusion-related acute lung injury risk-minimization measures-German haemovigilance data (2006-2010). Vox Sang 2012; 102: 317-323.
21. Lin Y, Saw CL, Hannach B, et al. Transfusion-related acute lung injury prevention measures and their impact at Canadian Blood Services. Transfusion 2012; 52: 567-574.
22. Nakazawa H, Ohnishi H, Okazaki H, et al. Impact of fresh-frozen plasma from male-only donors versus mixed-sex donors on postoperative respiratory function in surgical patients: a prospective case-controlled study. Transfusion 2009; 49: 2434-2441.
23. Toy P, Gajic O, Bacchetti P, et al. Transfusion related acute lung injury: incidence and risk factors. Blood 2012; 119: 1757-1767.
24. Vlaar AP, Binnekade JM, Prins D, et al. Risk factors and outcome of transfusion-related acute lung injury in the critically ill: a nested case-control study. Crit Care Med 2010; 38: 771-778.
25. Wiersum-Osselton JC, Middelburg RA, Beckers EA, et al. Male-only fresh-frozen plasma for transfusion-related acute lung injury prevention: before-and-after comparative cohort study. Transfusion 2011; 51: 1278-1283.
26. Wright SE, Snowden CP, Athey SC, et al. Acute lung injury after ruptured abdominal aortic aneurysm repair: the effect of excluding donations from females from the production of fresh frozen plasma. Crit Care Med 2008; 36: 1796-1802.
27. Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med 2009; 151: 264-269.
28. Wells GA, Shea B, O'Connell D, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. [cited 2013 Oct 19]. Available from: http://www.ohri.ca/programs/clinical-epidemiology/oxford.asp
29. Landis JR, Koch GG,. The measurement of observer agreement for categorical data. Biometrics 1977; 33: 159-174.
30. DerSimonian R, Kacker R,. Random-effects model for meta-analysis of clinical trials: an update. Contemp Clin Trials 2007; 28: 105-114.
31. Lumley T,. The R package rMeta, version 2.16. Foundation for Statistical Computing, Vienna, Austria. 2013 [cited 2013 Oct 19]. Available from: http://www.R-project.org/
32. Goldman M, Webert KE, Arnold DM, et al. Proceedings of a consensus conference: towards an understanding of TRALI. Transfus Med Rev 2005; 19: 2-31.
33. Triulzi DJ, Kleinman S, Kakaiya RM, et al. The effect of previous pregnancy and transfusion on HLA alloimmunization in blood donors: implications for a transfusion-related acute lung injury risk reduction strategy. Transfusion 2009; 49: 1825-1835.
34. Win N, Chapman CE, Bowles KM, et al. How much residual plasma may cause TRALI? Transfus Med 2008; 18: 276-280.
35. American Red Cross. Eligibility criteria by topic: medical treatments that affect eligibility. 2013. [cited 2013 Oct 20]. http://www.redcrossblood.org/donating-blood/eligibility-requirements/eligibility-criteria-topic#med-treatments
36. Reesink HW, Lee J, Keller A, et al. Measures to prevent transfusion-related acute lung injury (TRALI). Vox Sang 2012; 103: 231-259.
37. Sachs UJ, Kauschat D, Bein G,. White blood cell-reactive antibodies are undetectable in solvent/detergent plasma. Transfusion 2005; 45: 1628-1631.
38. Powers A, Stowell CP, Dzik WH, et al. Testing only donors with a prior history of pregnancy or transfusion is a logical and cost-effective transfusion-related acute lung injury prevention strategy. Transfusion 2008; 48: 2549-2558.
39. Marik PE, Corwin HL,. Acute lung injury following blood transfusion: expanding the definition. Crit Care Med 2008; 36: 3080-3084.
40. Moore SB,. Transfusion-related acute lung injury (TRALI): clinical presentation, treatment, and prognosis. Crit Care Med 2006; 34 (5 Suppl): S114-117.
41. Bux J, Sachs UJ,. The pathogenesis of transfusion-related acute lung injury (TRALI). Br J Haematol 2007; 136: 788-799.
42. Looney MR, Nguyen JX, Hu Y, et al. Platelet depletion and aspirin treatment protect mice in a two-event model of transfusion-related acute lung injury. J Clin Invest 2009; 119: 3450-3461.
43. Vlaar AP, Wolthuis EK, Hofstra JJ, et al. Mechanical ventilation aggravates transfusion-related acute lung injury induced by MHC-I class antibodies. Intensive Care Med 2010; 36: 879-887.
44. Vlaar AP, Kuipers MT, Hofstra JJ, et al. Mechanical ventilation and the titer of antibodies as risk factors for the development of transfusion-related lung injury. Crit Care Res Pract 2012; 2012: 720950.